| RS146185666 |
SON
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146185976 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS146186205 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 11 |
| RS146186348 |
KIF14
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 20, primary |
| RS146186857 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS146187042 |
C8B
|
Health Risk |
Pathogenic/Likely pathogenic |
Type II complement component 8 deficiency, Complement component 6 deficiency |
| RS146187044 |
MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS146187323 |
GAS2L2
|
Health Risk |
Conflicting classifications of pathogenicity |
GAS2L2-related disorder, Ciliary dyskinesia |
| RS1461886025 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1461895191 |
PDE6C
|
Health Risk |
Likely pathogenic |
— |
| RS146190504 |
WNK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146190510 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS1461905374 |
LDLRAP1
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1461907039 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS146190978 |
PHYH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146191537 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS146192032 |
TONSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1461925348 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS146193366 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperuricemia, pulmonary hypertension |
| RS1461946712 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1461947497 |
FAM20C
|
Health Risk |
Pathogenic |
FAM20C-related disorder, Lethal osteosclerotic bone dysplasia |
| RS146194900 |
KCNK18
|
Health Risk |
Pathogenic |
KCNK18-related neurodevelopmental disorder, KCNK18-related neurodevelopmental disorder |
| RS146195006 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Isolated cryptophthalmia |
| RS146195280 |
ABHD12
|
Health Risk |
Conflicting classifications of pathogenicity |
PHARC syndrome, PHARC syndrome |
| RS146195310 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS146195866 |
GYS2
|
Health Risk |
Pathogenic |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |
| RS146195955 |
CNGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy, Achromatopsia 2 |
| RS1461960812 |
POLH
|
Health Risk |
Pathogenic |
— |
| RS146196342 |
ACP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS146196839 |
DGAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
DGAT1-related disorder, DGAT1-related disorder |
| RS146197239 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1461973241 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS146198085 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1461981853 |
CANT1
|
Health Risk |
Pathogenic |
— |
| RS1461982823 |
CUBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome type 1 |
| RS146198369 |
NEBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, NEBL-related disorder |
| RS1461984773 |
SP7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1461992033 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS146199636 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Autosomal recessive nonsyndromic hearing loss 23 |
| RS146199720 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS146199863 |
EXPH5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146200173 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1462004544 |
ADAMTS13
|
Health Risk |
Pathogenic |
— |
| RS146200756 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS146201109 |
ADARB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1462011435 |
UNC93B1
|
Health Risk |
Likely pathogenic |
Herpes simplex encephalitis, susceptibility to |
| RS1462012083 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Inborn genetic diseases |
| RS146201511 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary insensitivity to pain with anhidrosis, Inborn genetic diseases |
| RS146201603 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS146202502 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia 10 |
| RS146202702 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 1, Inborn genetic diseases |
| RS1462028977 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS146202983 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1462031084 |
ADGRV1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS146203427 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Kartagener syndrome |
| RS1462038794 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1462048687 |
GLI3
|
Health Risk |
Likely pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS146205352 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS146205427 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome, Lethal multiple pterygium syndrome |
| RS1462060431 |
SPTA1
|
Health Risk |
Likely pathogenic |
Familial hemolytic anemia, Familial hemolytic anemia |
| RS146206123 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS1462064763 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS1462077116 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1462082548 |
SCAPER
|
Health Risk |
Pathogenic |
Intellectual developmental disorder and retinitis pigmentosa, IDDRP |
| RS146209388 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS1462094685 |
FKRP
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS1462096457 |
IVD
|
Health Risk |
Pathogenic/Likely pathogenic |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS146209687 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Inborn genetic diseases |
| RS146210693 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS146210785 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS1462108134 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, Ehlers-Danlos syndrome |
| RS1462109887 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS146212122 |
FLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146213322 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Inborn genetic diseases |
| RS146214639 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Pityriasis rubra pilaris, Psoriasis 2 |
| RS146215039 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1462159134 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Li-Fraumeni syndrome |
| RS1462161137 |
METTL23
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS146216767 |
WNK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1462170681 |
SLC12A6
|
Health Risk |
Pathogenic/Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Charcot-Marie-Tooth disease |
| RS146217095 |
C9
|
Health Risk |
Pathogenic/Likely pathogenic |
Complement component 9 deficiency, Complement component 9 deficiency |
| RS146217922 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS146218010 |
ANAPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rothmund-Thomson syndrome type 1, Rothmund-Thomson syndrome type 1 |
| RS146218439 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1462186598 |
POT1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1462190245 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS146219199 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS146219377 |
FANCF
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group F |
| RS146220085 |
KCND2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early myoclonic encephalopathy, KCND2-related disorder |
| RS146220228 |
WAS
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS146220233 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS146220690 |
MMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS146221263 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Occipital pachygyria and polymicrogyria, Inborn genetic diseases |
| RS146221635 |
SYCP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mycotic Aneurysm, Intracranial |
| RS146221660 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease 2, Dyskeratosis congenita |
| RS1462221945 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS146222625 |
ALDH4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS146222650 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS146223051 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS146223261 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |